An ASCO Education Session to Focus on New Therapeutic Developments in Pediatric Hodgkin Lymphoma

Speakers will highlight the importance of shared decision-making on the road to a standard of care.

Key Points

  • An ASCO Education Session will feature discussions about treatment advances in Hodgkin lymphoma (HL), including global perspectives and strategies for facilitating shared decision-making.
  • Specifically, presenters will provide an overview of HL treatment for children, adolescents, and young adults, both in North America and worldwide, as well as patient advocate–endorsed approaches to shared decision-making.

Attendees of the 2024 ASCO Annual Meeting (May 31-June 4 in Chicago) should look forward to the Education Session “Pediatric Hodgkin Lymphoma Treatment: Paving the Way for a Standard of Care and Shared Decision-Making,” which will include discussions on treatment advances in HL, global perspectives on disease management, and strategies for improving shared decision-making between providers, patients, and caregivers. The session will be held June 3 from 9:45 AM CDT through 10:30 CDT.

Login Or Register To Read Full Story